Pacific Biosciences Of California - 8 Year Stock Price History | PACB
Historical daily share price chart and data for Pacific Biosciences Of California since 2010 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Pacific Biosciences Of California as of December 14, 2018 is 7.47.
| Pacific Biosciences Of California Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 3.8640 | 2.7900 | 7.8200 | 2.0500 | 7.4700 | 182.95% |
| 2017 | 4.1788 | 4.3600 | 5.5700 | 2.5900 | 2.6400 | -30.53% |
| 2016 | 8.6401 | 13.1900 | 13.1900 | 3.8000 | 3.8000 | -71.06% |
| 2015 | 6.6356 | 7.8100 | 13.4500 | 3.6600 | 13.1300 | 67.47% |
| 2014 | 5.7342 | 5.0700 | 7.8400 | 4.1300 | 7.8400 | 49.90% |
| 2013 | 3.2431 | 1.8500 | 5.9800 | 1.8000 | 5.2300 | 207.65% |
| 2012 | 2.4529 | 2.9500 | 5.0400 | 1.1000 | 1.7000 | -39.29% |
| 2011 | 9.4028 | 16.3000 | 16.3000 | 2.2800 | 2.8000 | -82.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.112B | $0.093B |
| Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.279B | 21.97 |
| Intuitive Surgical (ISRG) | United States | $56.165B | 55.26 |
| Edwards Lifesciences (EW) | United States | $33.475B | 35.82 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $20.859B | 14.10 |
| IDEXX Laboratories (IDXX) | United States | $16.408B | 46.87 |
| ABIOMED (ABMD) | United States | $14.241B | 102.33 |
| Hologic (HOLX) | United States | $12.130B | 18.72 |
| Teleflex (TFX) | United States | $11.377B | 25.83 |
| Varian Medical Systems (VAR) | United States | $10.852B | 27.01 |
| DexCom (DXCM) | United States | $10.720B | 0.00 |
| STERIS (STE) | United Kingdom | $9.561B | 25.37 |
| Masimo (MASI) | United States | $5.673B | 36.78 |
| LivaNova (LIVN) | United Kingdom | $4.598B | 29.52 |
| Globus Medical (GMED) | United States | $4.389B | 27.51 |
| Penumbra (PEN) | United States | $4.327B | 261.25 |
| Integra LifeSciences Holdings (IART) | United States | $4.122B | 20.08 |
| Wright Medical Group (WMGI) | Netherlands | $3.442B | 0.00 |
| Cantel Medical (CMD) | United States | $3.310B | 32.65 |
| Inogen (INGN) | United States | $2.792B | 60.27 |
| Integer Holdings (ITGR) | United States | $2.729B | 22.84 |
| Halyard Health (AVNS) | United States | $2.274B | 20.49 |
| Glaukos (GKOS) | United States | $2.255B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.028B | 0.00 |
| OPKO Health (OPK) | United States | $1.842B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.535B | 0.00 |
| Nevro (NVRO) | United States | $1.192B | 0.00 |
| Luminex (LMNX) | United States | $1.138B | 41.16 |
| AxoGen (AXGN) | United States | $1.096B | 0.00 |
| Natus Medical (BABY) | United States | $1.082B | 22.71 |
| CryoLife (CRY) | United States | $1.057B | 92.19 |
| Orthofix (OFIX) | United States | $1.039B | 30.00 |
| Intersect ENT (XENT) | United States | $0.935B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.932B | 148.44 |
| Mesa Laboratories (MLAB) | United States | $0.799B | 47.23 |
| AngioDynamics (ANGO) | United States | $0.779B | 27.26 |
| Accelerate Diagnostics (AXDX) | United States | $0.699B | 0.00 |
| ViewRay (VRAY) | United States | $0.602B | 0.00 |
| Veracyte (VCYT) | United States | $0.495B | 0.00 |
| SI-BONE INC (SIBN) | United States | $0.491B | 0.00 |
| Sientra (SIEN) | United States | $0.441B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.422B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.391B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.367B | 0.00 |
| Neuronetics (STIM) | United States | $0.353B | 0.00 |
| Accuray (ARAY) | United States | $0.328B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.307B | 0.00 |
| Fluidigm (FLDM) | United States | $0.306B | 0.00 |
| IRadimed (IRMD) | United States | $0.295B | 77.20 |
| Nuvectra (NVTR) | United States | $0.293B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.263B | 41.50 |
| GenMark Diagnostics (GNMK) | United States | $0.256B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.253B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.203B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.173B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.108B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.103B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.099B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.092B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.088B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.085B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.067B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.065B | 0.00 |
| EDAP TMS (EDAP) | France | $0.064B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.042B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.040B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.038B | 0.00 |
| Vermillion (VRML) | United States | $0.035B | 0.00 |
| ConforMIS (CFMS) | United States | $0.033B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.027B | 0.00 |
| Dynatronics (DYNT) | United States | $0.021B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.021B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.019B | 0.00 |
| Neovasc (NVCN) | Canada | $0.015B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.014B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.011B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.008B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
